New Drugs: Dupilumab for Prurigo Nodularis
Dr. Ted Rosen discusses the FDA’s recent approval of dupilumab as the first FDA-approved treatment for adults with prurigo nodularis. By Ted Rosen, MD, FAADEditor-in-Chief Based upon the results of two phase 3 trials (PRIME, PRIME 2), the FDA has approved dupilumab (Dupixent, Sanofi Regeneron) for the treatment of prurigo nodularis in adults. Dupilumab is, […]